Challenges for Small Biopharmaceutical Companies
N Engl J Med
.
2017 Apr 27;376(17):1698.
doi: 10.1056/NEJMc1702644.
Authors
Richard A Moscicki
1
,
P K Tandon
2
Affiliations
1
Food and Drug Administration, Silver Spring, MD richard.moscicki@fda.hhs.gov.
2
Ultragenyx Pharmaceutical, Novato, CA.
PMID:
28445670
DOI:
10.1056/NEJMc1702644
No abstract available
Publication types
Letter
Comment
MeSH terms
Commerce*
Drug Industry*
Humans